Illumina Inc (ILMN)

$150.28 -3.67 (-2.38%)
Market Cap 22.96B
Revenue (ttm) 4.37B
Net Income (ttm) -1.22B
EPS (ttm) N/A
PE Ratio 35.31
Forward PE 30.42
Profit Margin -27.97%
Debt to Equity Ratio 0.42
Volume 2,765,000
Avg Vol 1,724,978
Day's Range N/A - N/A
Shares Out 152.80M
Stochastic %K 72%
Beta 1.41
Analysts Sell
Price Target $130.26

Company Profile

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other g...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 858 202 4500
Fax: 858 202 4545
Address:
5200 Illumina Way, San Diego, United States
SuperGreenToday
SuperGreenToday Jan. 23 at 12:58 PM
$ILMN Share Price: $153.99 Contract Selected: Sep 18, 2026 $155 Calls Buy Zone: $17.33 – $21.41 Target Zone: $30.03 – $36.70 Potential Upside: 64% ROI Time to Expiration: 237 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
DrBig
DrBig Jan. 23 at 12:48 PM
$ILMN took 500 share position at $96 buying covered calls since. Stock has been an endless cash register as new management gets it back on track with the help of AI
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 23 at 12:58 AM
$ILMN Share Price: $153.99 Contract Selected: Sep 18, 2026 $155 Calls Buy Zone: $18.53 – $22.89 Target Zone: $30.47 – $37.24 Potential Upside: 55% ROI Time to Expiration: 238 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Sunnytrading90
Sunnytrading90 Jan. 22 at 5:57 PM
$ILMN
0 · Reply
thelattehq
thelattehq Jan. 21 at 5:00 PM
$GRAL $ILMN https://www.thelattehq.com/p/grail-gral-the-long-game-in-early-cancer-detection
0 · Reply
WAJeff
WAJeff Jan. 21 at 5:00 PM
$ILMN 151.76 52 week high
0 · Reply
tievLeaf
tievLeaf Jan. 21 at 3:45 PM
$QSI Nuff said, just see this post by ARK recently and tell me if you think this price range of $1 FOR QUANTUM-SI ain't undervalued as fuck. Just FYI, they are categorizing Nurix Therapeutics at the same category with QSI and Nurix is currently at $19. $ILMN $SLS $FEMY $NRIX
2 · Reply
endo3
endo3 Jan. 20 at 9:38 PM
$PACB today $PACB is up 6%, $UNH 2%, $ILMN 1.5%, $TXG is up by 7% While rest of the market tanked. Any rationale?
0 · Reply
erevnon
erevnon Jan. 20 at 7:53 PM
Stifel maintains Illumina $ILMN at Buy and raises the price target from $135 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 14 at 6:35 PM
$ILMN Share Price: $142.75 Contract Selected: Jun 18, 2026 $145 Calls Buy Zone: $12.07 – $14.91 Target Zone: $22.84 – $27.91 Potential Upside: 79% ROI Time to Expiration: 154 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Latest News on ILMN
Illumina Gets Medicare Boost for Cancer Test, Shares Climb

Jan 20, 2026, 1:19 PM EST - 4 days ago

Illumina Gets Medicare Boost for Cancer Test, Shares Climb

Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology

Jan 20, 2026, 9:15 AM EST - 5 days ago

Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology

GRAIL Inc. - Illumina's Divested Holy Grail

Jan 20, 2026, 8:34 AM EST - 5 days ago

GRAIL Inc. - Illumina's Divested Holy Grail

GRAL

Illumina, Inc. (ILMN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 13, 2026, 2:25 PM EST - 11 days ago

Illumina, Inc. (ILMN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Illumina unveils dataset to speed up AI-powered drug discovery

Jan 13, 2026, 9:18 AM EST - 12 days ago

Illumina unveils dataset to speed up AI-powered drug discovery

Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery

Jan 13, 2026, 9:15 AM EST - 12 days ago

Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery

Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025

Jan 13, 2026, 9:00 AM EST - 12 days ago

Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025

Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026

Jan 12, 2026, 4:07 PM EST - 12 days ago

Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026

Illumina Appoints Dr. Eric Green as Chief Medical Officer

Jan 8, 2026, 4:30 PM EST - 16 days ago

Illumina Appoints Dr. Eric Green as Chief Medical Officer

Illumina and PREMIA partner to expand clinical access to CGP in Asia

Jan 8, 2026, 8:07 AM EST - 17 days ago

Illumina and PREMIA partner to expand clinical access to CGP in Asia

Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis

Jan 6, 2026, 9:15 AM EST - 19 days ago

Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis

Illumina To Webcast Upcoming Investor Conference

Dec 16, 2025, 4:05 PM EST - 5 weeks ago

Illumina To Webcast Upcoming Investor Conference

Santa Rally Looms: These 5 Stocks Often Deliver Gifts To Investors

Dec 16, 2025, 2:29 PM EST - 5 weeks ago

Santa Rally Looms: These 5 Stocks Often Deliver Gifts To Investors

CAT FCX GS JPM

Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually

Dec 11, 2025, 9:15 AM EST - 6 weeks ago

Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually

Illumina, Inc. (ILMN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

Nov 19, 2025, 2:23 PM EST - 2 months ago

Illumina, Inc. (ILMN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study

Nov 12, 2025, 12:00 PM EST - 2 months ago

Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study

Final Trades: Morgan Stanley, Cisco Systems, Illumina and FTAI Aviation

Nov 10, 2025, 1:16 PM EST - 2 months ago

Final Trades: Morgan Stanley, Cisco Systems, Illumina and FTAI Aviation

CSCO FTAI MS

Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks

Nov 10, 2025, 12:15 PM EST - 2 months ago

Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks

LAB

Illumina Responds to Positive Updates from Chinese Ministry of Commerce

Nov 5, 2025, 5:16 PM EST - 2 months ago

Illumina Responds to Positive Updates from Chinese Ministry of Commerce

DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars

Oct 31, 2025, 12:01 PM EDT - 3 months ago

DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars

Illumina, Inc. (ILMN) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 10:26 PM EDT - 3 months ago

Illumina, Inc. (ILMN) Q3 2025 Earnings Call Transcript

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025

Oct 30, 2025, 4:05 PM EDT - 3 months ago

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025

Illumina: Innovation Outweighs Short-Term Risks - A Long-Term Buy Ahead Of Q3 Earnings

Oct 21, 2025, 2:16 PM EDT - 3 months ago

Illumina: Innovation Outweighs Short-Term Risks - A Long-Term Buy Ahead Of Q3 Earnings

Final Trades: Illumina, Columbia Banking, Alibaba and JPMorgan Chase

Oct 20, 2025, 4:21 PM EDT - 3 months ago

Final Trades: Illumina, Columbia Banking, Alibaba and JPMorgan Chase

BABA COLB JPM

Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights

Oct 15, 2025, 9:15 AM EDT - 3 months ago

Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

Oct 15, 2025, 9:15 AM EDT - 3 months ago

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

WGS

Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025

Oct 14, 2025, 4:05 PM EDT - 3 months ago

Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025

Illumina launches new business to accelerate technology and data-driven discovery

Oct 1, 2025, 9:05 AM EDT - 4 months ago

Illumina launches new business to accelerate technology and data-driven discovery

ILMN Stock vs. IQV Stock

Sep 26, 2025, 9:40 AM EDT - 4 months ago

ILMN Stock vs. IQV Stock

IQV

Illumina advances personalized cancer care with new pharma development partnerships

Sep 23, 2025, 9:15 AM EDT - 4 months ago

Illumina advances personalized cancer care with new pharma development partnerships

Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine

Sep 18, 2025, 9:15 AM EDT - 4 months ago

Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine

ALNY

Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development

Sep 3, 2025, 9:15 AM EDT - 5 months ago

Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development

LAB

mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 5 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX DHR GRAL IONS MRNA RGEN

Illumina: The Stock Is Still Undervalued

Aug 4, 2025, 4:23 AM EDT - 6 months ago

Illumina: The Stock Is Still Undervalued

These Analysts Boost Their Forecasts On Illumina Following Upbeat Results

Aug 1, 2025, 12:02 PM EDT - 6 months ago

These Analysts Boost Their Forecasts On Illumina Following Upbeat Results

Illumina, Inc. (ILMN) Q2 2025 Earnings Call Transcript

Aug 1, 2025, 1:25 AM EDT - 6 months ago

Illumina, Inc. (ILMN) Q2 2025 Earnings Call Transcript

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025

Jul 31, 2025, 4:05 PM EDT - 6 months ago

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025

Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling

Jul 30, 2025, 9:15 AM EDT - 6 months ago

Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling

Illumina Stock: What Went Wrong And Why It's Best To Stay Away

Jul 17, 2025, 7:45 AM EDT - 6 months ago

Illumina Stock: What Went Wrong And Why It's Best To Stay Away

Illumina: Higher Profit Margin Despite GRAIL Divestiture And Macroeconomic Headwinds

Jul 12, 2025, 3:46 AM EDT - 7 months ago

Illumina: Higher Profit Margin Despite GRAIL Divestiture And Macroeconomic Headwinds

Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025

Jul 10, 2025, 4:05 PM EDT - 7 months ago

Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025

Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year

Jul 10, 2025, 9:15 AM EDT - 7 months ago

Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy

Jun 23, 2025, 7:13 AM EDT - 7 months ago

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy

LAB

Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome Profiling

Jun 18, 2025, 9:00 AM EDT - 7 months ago

Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome Profiling

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

Jun 10, 2025, 4:01 PM EDT - 8 months ago

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis

May 29, 2025, 2:01 PM EDT - 8 months ago

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis

Illumina, Inc. (ILMN) Bernstein 41st Annual Strategic Decisions Conference (Transcript)

May 29, 2025, 12:18 AM EDT - 8 months ago

Illumina, Inc. (ILMN) Bernstein 41st Annual Strategic Decisions Conference (Transcript)

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

May 28, 2025, 12:22 PM EDT - 8 months ago

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

AMGN BIIB DHR GILD IBB NVS SDGR

Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies

May 28, 2025, 9:15 AM EDT - 8 months ago

Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies

Signios Bio and Illumina Announce Grant to Maximize Discovery Power with Industry's Largest NGS-Based Proteomics Panel

May 19, 2025, 11:47 AM EDT - 8 months ago

Signios Bio and Illumina Announce Grant to Maximize Discovery Power with Industry's Largest NGS-Based Proteomics Panel

SuperGreenToday
SuperGreenToday Jan. 23 at 12:58 PM
$ILMN Share Price: $153.99 Contract Selected: Sep 18, 2026 $155 Calls Buy Zone: $17.33 – $21.41 Target Zone: $30.03 – $36.70 Potential Upside: 64% ROI Time to Expiration: 237 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
DrBig
DrBig Jan. 23 at 12:48 PM
$ILMN took 500 share position at $96 buying covered calls since. Stock has been an endless cash register as new management gets it back on track with the help of AI
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 23 at 12:58 AM
$ILMN Share Price: $153.99 Contract Selected: Sep 18, 2026 $155 Calls Buy Zone: $18.53 – $22.89 Target Zone: $30.47 – $37.24 Potential Upside: 55% ROI Time to Expiration: 238 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Sunnytrading90
Sunnytrading90 Jan. 22 at 5:57 PM
$ILMN
0 · Reply
thelattehq
thelattehq Jan. 21 at 5:00 PM
$GRAL $ILMN https://www.thelattehq.com/p/grail-gral-the-long-game-in-early-cancer-detection
0 · Reply
WAJeff
WAJeff Jan. 21 at 5:00 PM
$ILMN 151.76 52 week high
0 · Reply
tievLeaf
tievLeaf Jan. 21 at 3:45 PM
$QSI Nuff said, just see this post by ARK recently and tell me if you think this price range of $1 FOR QUANTUM-SI ain't undervalued as fuck. Just FYI, they are categorizing Nurix Therapeutics at the same category with QSI and Nurix is currently at $19. $ILMN $SLS $FEMY $NRIX
2 · Reply
endo3
endo3 Jan. 20 at 9:38 PM
$PACB today $PACB is up 6%, $UNH 2%, $ILMN 1.5%, $TXG is up by 7% While rest of the market tanked. Any rationale?
0 · Reply
erevnon
erevnon Jan. 20 at 7:53 PM
Stifel maintains Illumina $ILMN at Buy and raises the price target from $135 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 14 at 6:35 PM
$ILMN Share Price: $142.75 Contract Selected: Jun 18, 2026 $145 Calls Buy Zone: $12.07 – $14.91 Target Zone: $22.84 – $27.91 Potential Upside: 79% ROI Time to Expiration: 154 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 14 at 5:59 PM
$ILMN Current Stock Price: $141.35 Contracts to trade: $140 ILMN Jan 16 2026 Call Entry: $2.55 Exit: $3.73 ROI: 46% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
DrewskiC99
DrewskiC99 Jan. 13 at 7:39 PM
$ILMN aging like fine wine
0 · Reply
prismmarketview
prismmarketview Jan. 13 at 6:03 PM
Illumina $ILMN Unveils the Billion Cell Atlas to Accelerate AI-Powered Drug Discovery https://prismmarketview.com/illumina-unveils-the-billion-cell-atlas-to-accelerate-ai-powered-drug-discovery/
0 · Reply
ZacksResearch
ZacksResearch Jan. 13 at 6:00 AM
$ILMN jumps 4.1% on new Connected Multiomics launch 🚀 The innovative cloud-based platform is intended to advance precision health discovery, enhancing drug development breakthroughs with AI-enabled analysis capabilities. Discover how this could shape ILMN's future here 👉 https://www.zacks.com/stock/news/2815503/illuminas-new-connected-multiomics-platform-set-to-boost-its-stock?cid=sm-stocktwits-2-2815503-body-28339&ADID=SYND_STOCKTWITS_TWEET_2_2815503_BODY_28339
0 · Reply
TimisoaraTitans
TimisoaraTitans Jan. 13 at 1:58 AM
$A $ILMN $TMO $WGS 😦
0 · Reply
WAJeff
WAJeff Jan. 12 at 8:25 PM
$ILMN I am very late to the turn here but added at $145.44
1 · Reply
ZacksResearch
ZacksResearch Jan. 12 at 1:12 PM
$ILMN jumps 4.1% on new Connected Multiomics launch 🚀 The innovative cloud-based platform is intended to advance precision health discovery, enhancing drug development breakthroughs with AI-enabled analysis capabilities. Discover how this could shape ILMN's future here 👉 https://www.zacks.com/stock/news/2815503/illuminas-new-connected-multiomics-platform-set-to-boost-its-stock?cid=sm-stocktwits-2-2815503-body-28339&ADID=SYND_STOCKTWITS_TWEET_2_2815503_BODY_28339
0 · Reply
ZacksResearch
ZacksResearch Jan. 12 at 12:12 PM
$ILMN just leveled up its precision health play — is the market paying attention? ILMN’s Connected Multiomics platform was launched after early user input and is positioned to advance precision health research, a strategic move that could strengthen its story and support the stock 🚀 See why this platform launch matters for ILMN’s next phase 👉 https://www.zacks.com/stock/news/2815503/illuminas-new-connected-multiomics-platform-set-to-boost-its-stock?cid=sm-stocktwits-2-2815503-teaser-28338&ADID=SYND_STOCKTWITS_TWEET_2_2815503_TEASER_28338
0 · Reply
Brofessional
Brofessional Jan. 10 at 1:29 AM
$ILMN Cathie Woods ARK sold, that means this about to rip to the next level
2 · Reply
HollywoodWolf007
HollywoodWolf007 Jan. 9 at 12:25 PM
$ILMN . $ISRG .
1 · Reply
EderT
EderT Jan. 6 at 10:12 PM
$ILMN sold my shares after hours
0 · Reply
M_Chromatic
M_Chromatic Jan. 6 at 12:21 PM
$ILMN Getting above Point of Control volume shelf (most volume traded from March 2020) on the weekly chart. Next volume shelf isn't until the 190s. AVWAP is in the 158s.
1 · Reply